Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiwei Bai

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Cancer Biology & Medicine|March 27, 2023
Artificial intelligence-based comprehensive analysis of immune-stemness-tumor budding profile to predict survival of patients with pancreatic adenocarcinomaTianxing Zhou, Quan Man, Xueyang Li, et al.
International Journal of General Medicine|January 10, 2022
Efficacy of Standardized Rehabilitation in the Treatment of Diastasis Rectus Abdominis in Postpartum WomenJing Hu, Juanfen Gu, Zhiyan Yu, et al.
Cancer Research|March 11, 2026
The SDC1-ENO1 Axis in Cancer-Associated Fibroblasts Generates a Lactate-Rich Microenvironment that Drives Tumor RadioresistanceXupeng Hou, Moran Chen, Xiaojing Guo, et al.
Colloids and Surfaces. B, Biointerfaces|January 10, 2024
Hippocampal-derived extracellular vesicle synergistically deliver active adenosine hippocampus targeting to promote cognitive recovery after strokeLing-Kun Zhang, Li Liu, Qingpeng Liu, et al.
Gut|March 6, 2021
ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4Tianxing Zhou, Jing Liu, Yongjie Xie, et al.
Colloids and Surfaces. B, Biointerfaces|June 8, 2024
Reactive oxygen species produced by photodynamic therapy enhance docosahexaenoic acid lipid peroxidation and induce the death of breast cancer cellsWeiwei Bai, Yongyong Xue, Yiyan Guo, et al.
Gut|January 9, 2026
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapyJing Liu, Xupeng Hou, Lin Li, et al.
The Journal of Experimental Medicine|February 9, 2019
Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinomaJing Liu, Wenna Jiang, Kaili Zhao, et al.
Gastroenterology|March 16, 2024
Targeting ESE3/EHF With Nifurtimox Inhibits CXCR2<sup>+</sup> Neutrophil Infiltration and Overcomes Pancreatic Cancer Resistance to Chemotherapy and ImmunotherapyYongjie Xie, Tianxing Zhou, Xueyang Li, et al.
International Journal of Biological Macromolecules|September 6, 2023
Preparation of injectable porcine skin-derived collagen and its application in delaying skin aging by promoting the adhesion and chemotaxis of skin fibroblastsHe Ni, Chao Liu, Lili Kong, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Cancer Biology & Medicine|March 27, 2023
Artificial intelligence-based comprehensive analysis of immune-stemness-tumor budding profile to predict survival of patients with pancreatic adenocarcinomaTianxing Zhou, Quan Man, Xueyang Li, et al.
International Journal of General Medicine|January 10, 2022
Efficacy of Standardized Rehabilitation in the Treatment of Diastasis Rectus Abdominis in Postpartum WomenJing Hu, Juanfen Gu, Zhiyan Yu, et al.
Cancer Research|March 11, 2026
The SDC1-ENO1 Axis in Cancer-Associated Fibroblasts Generates a Lactate-Rich Microenvironment that Drives Tumor RadioresistanceXupeng Hou, Moran Chen, Xiaojing Guo, et al.
Colloids and Surfaces. B, Biointerfaces|January 10, 2024
Hippocampal-derived extracellular vesicle synergistically deliver active adenosine hippocampus targeting to promote cognitive recovery after strokeLing-Kun Zhang, Li Liu, Qingpeng Liu, et al.
Gut|March 6, 2021
ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4Tianxing Zhou, Jing Liu, Yongjie Xie, et al.
Colloids and Surfaces. B, Biointerfaces|June 8, 2024
Reactive oxygen species produced by photodynamic therapy enhance docosahexaenoic acid lipid peroxidation and induce the death of breast cancer cellsWeiwei Bai, Yongyong Xue, Yiyan Guo, et al.
Gut|January 9, 2026
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapyJing Liu, Xupeng Hou, Lin Li, et al.
The Journal of Experimental Medicine|February 9, 2019
Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinomaJing Liu, Wenna Jiang, Kaili Zhao, et al.
Gastroenterology|March 16, 2024
Targeting ESE3/EHF With Nifurtimox Inhibits CXCR2<sup>+</sup> Neutrophil Infiltration and Overcomes Pancreatic Cancer Resistance to Chemotherapy and ImmunotherapyYongjie Xie, Tianxing Zhou, Xueyang Li, et al.
International Journal of Biological Macromolecules|September 6, 2023
Preparation of injectable porcine skin-derived collagen and its application in delaying skin aging by promoting the adhesion and chemotaxis of skin fibroblastsHe Ni, Chao Liu, Lili Kong, et al.
Pageof 5